|
1
|
Fletcher CD, Unni KK and Mertens F; WHO;
IARC. WHO classification of tumours: Pathology and genetics of
tumours of soft tissue and bone. 4th edition. IARC Press; Lyon,
France: 2002
|
|
2
|
Bielack SS, Kempf-Bielack B, Delling G, et
al: Prognostic factors in high-grade osteosarcoma of the
extremities or trunk: an analysis of 1,702 patients treated on
neoadjuvant cooperative osteosarcoma study group protocols. J Clin
Oncol. 20:776–790. 2002. View Article : Google Scholar
|
|
3
|
Ferrari S, Smeland S, Mercuri M, et al:
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose
methotrexate, cisplatin, and doxorubicin for patients with
localized osteosarcoma of the extremity: a joint study by the
Italian and Scandinavian Sarcoma Groups. J Clin Oncol.
23:8845–8852. 2005. View Article : Google Scholar
|
|
4
|
Abramson DH, Ellsworth RM, Kitchin FD and
Tung G: Second nonocular tumors in retinoblastoma survivors. Are
they radiation-induced? Ophthalmology. 91:1351–1355. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kitchin FD and Ellsworth RM: Pleiotropic
effects of the gene for retinoblastoma. J Med Genet. 11:244–246.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ladanyi M and Gorlick R: Molecular
pathology and molecular pharmacology of osteosarcoma. Pediatr
Pathol Mol Med. 19:391–413. 2000. View Article : Google Scholar
|
|
7
|
Hung J and Anderson R: p53: functions,
mutations and sarcomas. Acta Orthop Scand Suppl. 273:68–73.
1997.PubMed/NCBI
|
|
8
|
Miller CW, Aslo A, Won A, Tan M, Lampkin B
and Koefflar HP: Alterations of the p53, Rb and MDM2 genes in
osteosarcoma. J Cancer Res Clin Oncol. 122:559–565. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Noble-Topham SE, Burrow SR, Kandel RA, et
al: SAS is amplified predominantly in surface osteosarcoma. J
Orthop Res. 14:700–705. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paoloni M, Davis S, Lana S, et al: Canine
tumor cross-species genomics uncovers targets linked to
osteosarcoma progression. BMC Genomics. 10:6252009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fujita A, Sato JR, de Rodrigues LO,
Ferreira CE and Sogayar MC: Evaluating different methods of
microarray data normalization. BMC Bioinformatics. 7:4692006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Troyanskaya O, Cantor M, Sherlock G, et
al: Missing value estimation methods for DNA microarrays.
Bioinformatics. 17:520–525. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pollard KS, Dudoit S and van der Laan MJ:
Multiple testing procedures: R multtest package and applications to
genomics. Bioinformatics and Computaional Biology Solutions using R
and Bioconductor. Statistics for Biology and Health 2005. 249–271.
2005.
|
|
14
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: a practical and powerful approach to
multiple testing. J R Statist Soc. B. 289–300. 1995.
|
|
15
|
Szklarczyk D, Franceschini A, Kuhn M, et
al: The STRING database in 2011: functional interaction networks of
proteins, globally integrated and scored. Nucleic Acids Res.
39:D561–D568. 2011. View Article : Google Scholar
|
|
16
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: new features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rivera CG, Vakil R and Bader JS: NeMo:
network module identification in Cytoscape. BMC Bioinformatics.
11:S612010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maere S, Heymans K and Kuiper M: BiNGO: a
Cytoscape plugin to assess overrepresentation of gene ontology
categories in biological networks. Bioinformatics. 21:3448–3449.
2005. View Article : Google Scholar
|
|
19
|
Olsen BR: Mutations in collagen genes
resulting in metaphyseal and epiphyseal dysplasias. Bone.
17:S45–S49. 1995. View Article : Google Scholar
|
|
20
|
Prockop DJ and Kivirikko KI: Collagens:
molecular biology, diseases, and potentials for therapy. Ann Rev
Biochem. 64:403–434. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vikkula M, Metsäranta M and Ala-Kokko L:
Type II collagen mutations in rare and common cartilage diseases.
Ann Med. 26:107–114. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ghosh AK: Factors involved in the
regulation of type I collagen gene expression: implication in
fibrosis. Exp Biol Med. 227:301–314. 2002.PubMed/NCBI
|
|
23
|
Branton MH and Kopp JB: TGF-β and
fibrosis. Microbes Infect. 1:1349–1365. 1999.
|
|
24
|
Blobe GC, Schiemann WP and Lodish HF: Role
of transforming growth factor β in human disease. N Engl J Med.
342:1350–1358. 2000.
|
|
25
|
Chen SJ, Yuan W, Mori Y, Levenson A,
Trojanowska M and Varga J: Stimulation of type I collagen
transcription in human skin fibroblasts by TGF-β: involvement of
Smad 3. J Invest Dermatol. 112:49–57. 1999.
|
|
26
|
Mignatti P and Rifkin DB: Biology and
biochemistry of proteinases in tumor invasion. Physiol Rev.
73:161–195. 1993.PubMed/NCBI
|
|
27
|
Holmbeck K, Bianco P, Caterina J, et al:
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and
connective tissue disease due to inadequate collagen turnover.
Cell. 99:81–92. 1999. View Article : Google Scholar
|
|
28
|
Makareeva E, Han S, Vera JC, et al:
Carcinomas contain a matrix metalloproteinase-resistant isoform of
type I collagen exerting selective support to invasion. Cancer Res.
70:4366–4374. 2010. View Article : Google Scholar
|
|
29
|
Yong HY and Moon A: Roles of
calcium-binding proteins, S100A8 and S100A9, in invasive phenotype
of human gastric cancer cells. Arch Pharm Res. 30:75–81. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen PN, Kuo WH, Chiang CL, et al: Black
rice anthocyanins inhibit cancer cells invasion via repressions of
MMPs and u-PA expression. Chem Biol Interact. 163:218–229. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Itoh Y and Seiki M: MT1-MMP: a potent
modifier of pericellular microenvironment. J Cell Physiol. 206:1–8.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nabha SM, dos Santos EB, Yamamoto HA, et
al: Bone marrow stromal cells enhance prostate cancer cell invasion
through type I collagen in an MMP-12 dependent manner. Int J
Cancer. 122:2482–2490. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mori K, Enokida H, Kagara I, et al: CpG
hypermethylation of collagen type I alpha 2 contributes to
proliferation and migration activity of human bladder cancer. Int J
Oncol. 34:1593–1602. 2009.PubMed/NCBI
|
|
34
|
Pratap J, Galindo M, Zaidi SK, et al: Cell
growth regulatory role of Runx2 during proliferative expansion of
preosteoblasts. Cancer Res. 63:5357–5362. 2003.PubMed/NCBI
|
|
35
|
Thomas DM, et al: Terminal osteoblast
differentiation, mediated by runx2 and p27KIP1, is disrupted in
osteosarcoma. J Cell Biology. 167:925–934. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thomas DM, Carty SA, Piscopo DM, et al:
The retinoblastoma protein acts as a transcriptional coactivator
required for osteogenic differentiation. Mol Cell. 8:303–316. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jeon DG, Lee SY and Kim JW: Bone primary
sarcomas undergone unplanned intralesional procedures-the
possibility of limb salvage and their oncologic results. J Surg
Oncol. 94:592–598. 2006. View Article : Google Scholar
|
|
38
|
Ayerza MA, Muscolo DL, Aponte-Tinao LA and
Farfalli G: Effect of erroneous surgical procedures on recurrence
and survival rates for patients with osteosarcoma. Clin Orthop
Relat Res. 452:231–235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bramer JA, Abudu AA, Tillman RM, Carter
SR, Sumathi VP and Grimer RJ: Pre-and post-chemotherapy alkaline
phosphatase levels as prognostic indicators in adults with
localised osteosarcoma. Eur J Cancer. 41:2846–2852. 2005.
View Article : Google Scholar : PubMed/NCBI
|
